(Q34995066)

5 August 2017

title

Efficacy and safety of once-daily aclidinium in chronic obstructive pulmonary disease (English)

1 reference

chronic obstructive pulmonary disease

5 August 2017

main subject

0 references

Leonardo Fabbri

6

0 references

author name string

Paul W Jones

1

1 reference

5 August 2017

Stephen I Rennard

2

1 reference

5 August 2017

Alvar Agusti

3

1 reference

5 August 2017

Pascal Chanez

4

1 reference

5 August 2017

Helgo Magnussen

5

1 reference

5 August 2017

James F Donohue

7

1 reference

5 August 2017

Eric D Bateman

8

1 reference

5 August 2017

Nicholas J Gross

9

1 reference

5 August 2017

Rosa Lamarca

10

1 reference

5 August 2017

Cynthia Caracta

11

1 reference

5 August 2017

Esther Garcia Gil

12

1 reference

5 August 2017

publication date

26 April 2011

1 reference

5 August 2017

1 reference

5 August 2017

volume

12

1 reference

5 August 2017

page(s)

55

1 reference

Changing patterns in long-acting bronchodilator trials in chronic obstructive pulmonary disease

5 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3098801

Activity of aclidinium bromide, a new long-acting muscarinic antagonist: a phase I study

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3098801

Aclidinium bromide, a new, long-acting, inhaled muscarinic antagonist: in vitro plasma inactivation and pharmacological activity of its main metabolites.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3098801

Bronchodilatory effects of aclidinium bromide, a long-acting muscarinic antagonist, in COPD patients

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3098801

Characterization of aclidinium bromide, a novel inhaled muscarinic antagonist, with long duration of action and a favorable pharmacological profile.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3098801

Aclidinium bromide provides long-acting bronchodilation in patients with COPD.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3098801

A 4-year trial of tiotropium in chronic obstructive pulmonary disease

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3098801

Effect of tiotropium on health-related quality of life as a primary efficacy endpoint in COPD.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3098801

Outcomes for COPD pharmacological trials: from lung function to biomarkers.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3098801

A randomized controlled trial to assess the efficacy of tiotropium in Canadian patients with chronic obstructive pulmonary disease

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3098801

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3098801

Minimal clinically important differences in COPD lung function

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3098801

The MCID of the transition dyspnea index is a total score of one unit

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3098801

Tiotropium for stable chronic obstructive pulmonary disease: A meta-analysis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3098801

The effect of tiotropium on exacerbations and airflow in patients with COPD.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3098801

Prevention of exacerbations of chronic obstructive pulmonary disease with tiotropium, a once-daily inhaled anticholinergic bronchodilator: a randomized trial

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3098801

Standardisation of spirometry

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3098801

The role of anticholinergics in chronic obstructive pulmonary disease.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3098801

Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPD

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3098801

Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3098801

Peak inspiratory flow through the Genuair inhaler in patients with moderate or severe COPD.

8 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F1465-9921-12-55

A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F1465-9921-12-55

A 6-month, placebo-controlled study comparing lung function and health status changes in COPD patients treated with tiotropium or salmeterol

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F1465-9921-12-55

Safety and pharmacokinetics of single doses of aclidinium bromide, a novel long-acting, inhaled antimuscarinic, in healthy subjects.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3098801

St. George's Respiratory Questionnaire: MCID

26 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21518460

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Pooled clinical trial analysis of tiotropium safety

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21518460

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Aclidinium inhibits cholinergic and tobacco smoke-induced MUC5AC in human airways

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21518460

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1465-9921-12-55

1 reference

Dimensions Publication ID

5 August 2017

0 references

0 references

1 reference

5 August 2017

1 reference